Company Director at $MRCY Sells 4,832 Shares in Insider Sale

A recent disclosure reveals that Howard L Lance, a director at $MRCY, recently disposed of 4,832 shares of the company on 02-25-2026, garnering an estimated $429,959 from the transaction. Data regarding this sale was obtained from a recent SEC filing, indicating a movement of about 15.1% of their shares of this stock class. Following this sale, Lance now holds 27,272 shares of this particular $MRCY stock class.
Insider trading activity concerning $MRCY shows that insiders have engaged in 8 transactions on the open market within the past six months. Among these trades, there have been 0 purchases and 8 sales. Notable recent actions involving $MRCY stock by insiders over the previous 6 months include the sale of 1,400,000 shares for an estimated $107,850,000 by PARTNERS MANAGEMENT, LP JANA, 4,832 shares sold for an estimated $429,959 by Howard L Lance, 2,287 shares sold for an estimated $191,091 by STUART KUPINSKY (EVP, CLO & Corp Sec), and 1,978 shares sold by DOUGLAS MUNRO (SVP, CAO) for an estimated $151,117. Additionally, DEBORA A PLUNKETT sold 1,700 shares for an estimated $125,784.
In terms of hedge fund activity, there have been significant changes with 164 institutional investors adding shares of $MRCY stock to their portfolio, while 173 have reduced their positions in the most recent quarter. Among the noteworthy recent moves include the removal of 1,503,684 shares (-60.4%) from their portfolio by WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC in Q4 2025, totaling an estimated $109,783,968, as well as the addition of 1,009,297 shares (+360.0%) by AMERIPRISE FINANCIAL INC in the same period, amounting to an estimated $73,688,773.
$MRCY reported revenues of $232.9M in Q2 2026, reflecting a 4.37% increase compared to the corresponding period in the previous year. For more detailed financial information on $MRCY, refer to Quiver Quantitative’s MRCY stock page.
Analysis of analyst ratings on $MRCY shows that in recent months, 2 firms have issued buy ratings on the stock, while 1 firm has issued a sell rating. Some of the recent analyst ratings include a “Sell” rating issued by Goldman Sachs on 01/20/2026, a “Buy” rating issued by Truist Securities on 10/15/2025, and an “Outperform” rating by RBC Capital on 10/01/2025. To track analyst ratings and price targets for $MRCY, visit Quiver Quantitative’s $MRCY forecast page.